SCHEMBL38663358

SCHEMBL38663358

CC(C)(C)OC(=O)N1CCN(c2cncc(Cl)n2)C2CC21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 4/20 0.37
▸ OPRK1 P41145 1/20 0.35
▸ LCK P06239 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38663338 0.85 GPR119 (0.38) GPR119MEN1HPGDKMT2AHSD17B10
SCHEMBL5350081 0.80 PARP1 (0.51) GPR119HDAC1PARP1
SCHEMBL38666673 0.79 GPR119 (0.44) GPR119JAK3POLBUSP30CKS1B
SCHEMBL38666128 0.79 NR1H2 (0.46) GPR119OPRK1JAK3BTKMEN1
SCHEMBL38666762 0.77 MAP4K4 (0.53) GPR119JAK3BTKMEN1HPGD
SCHEMBL38665917 0.77 MAP4K4 (0.53) GPR119JAK3BTKMEN1HPGD
SCHEMBL38666760 0.77 GPR119 (0.48) GPR119POLBCKS1BSKP1SKP2
SCHEMBL38665383 0.77 GPR119 (0.48) GPR119POLBCKS1BSKP1SKP2
SCHEMBL38666102 0.76 MAP4K4 (0.41) GPR119JAK3BTKMEN1HPGD
SCHEMBL38664361 0.76 PARP1 (0.37) GPR119JAK3BTKMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026106389-A1 NMT INHIBITOR AND USE THEREOF 주식회사 이노보테라퓨틱스 2026-05-21 — — WO disclosed
Send feedback